Yeah, the last thing Big Pharma would ever want to do is cut down on the incidence of a sexually transmitted virus that leads to a sickness that, in the cases it’s not rapidly lethal, requires expensive treatment and long term monitoring. Especially with a vaccine that would probably only be marketed to the population of highest risk-- heck, I bet there’d be moral backlash from the Religious Right against such a shot, making it even less profitable.